47 73 10 22 00
|Mr. Jon Olav Odegard||Chief Exec. Officer||1.7M||N/A||N/A|
|Dr. Bomi Framroze||Chief Scientific Officer||21.73M||N/A||1961|
|Mr. James Berger||Chief Commercial Officer||7.81M||N/A||N/A|
|Ms. Angelika Florvaag||Chief Quality Officer||822k||N/A||N/A|
|Ms. Christel Elise Kanli||CFO & COO||N/A||N/A||N/A|
|Dr. Crawford Currie||Head of Medical R&D and Director||N/A||N/A||N/A|
|Dr. Tanja Schaffer||EVP of Global Ingredients Division & CEO of HBC Switzerland GmbH||N/A||N/A||N/A|
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for supporting healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome (IBS) and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo, an hair, skin, and nails health treatment and antioxidant; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA’s ISS governance QualityScore as of 1 March 2023 is 7. The pillar scores are Audit: 10; Board: 5; Shareholder rights: 1; Compensation: 8.